Biotech | November 17, 2021
Pfizer seeks EUA from U.S. FDA for Covid-19 drug
If approved or authorized, Paxlovid would be the first oral antiviral of its kind, to combat SARS-CoV-2
If approved or authorized, Paxlovid would be the first oral antiviral of its kind, to combat SARS-CoV-2
Data demonstrates Ronapreve reduced risk of hospitalisation in certain patients and reduced risk of symptomatic Covid-19 infections in people exposed to the virus
A final decision regarding the approval of Ronapreve is expected from the European Commission shortly
Applications remain under review by others including U.S. Food and Drug Administration and the European Medicines Agency
_256_384.jpg)
Both parties are expected to invest a total of US $ 1 million to establish the brand
Filing marks first protein-based vaccine submitted to MHRA for authorization
It’s the company’s fourth manufacturing site worldwide. Others are located in the US, UK and China
New safety data show a consistent benefit-risk profile across all Ocrevus clinical trials
It becomes the first ophthalmology biosimilar to gain FDA approval in the United States
This is the third acquisition by Healthium this year apart from AbGel business in India and VitalCare in the UK
Subscribe To Our Newsletter & Stay Updated
